GSK names new chief executive
GlaxoSmithKline has announced that Emma Walmsley will take over from current chief executive Andrew Witty following his retirement at the end of March next year.
Read More
Tag: Andrew Witty
- CERo reports encouraging early data from phase 1 trial of CER‑1236
- ENA Respiratory begins dosing in phase 2 study of INNA‑051 nasal spray
- Argo Biopharma doses first patient in phase 2b trial of BW‑20829
- Akari files new patent and advances second ADC targeting CEACAM5
- BioMed X launches kidney disease project in partnership with the government of Barbados
